[ Price : $8.95]
Gamida Cell completes a rolling BLA submission for omidubicel, indicated for patients with blood cancers in need of stem cell tran...[ Price : $8.95]
Centessa Pharmaceuticals discontinues its development of lixivaptan for autosomal dominant polycystic kidney disease after due to ...[ Price : $8.95]
FDA says a cybersecurity vulnerability in some Illumina next-generation sequencing instruments could affect patient results.[ Price : $8.95]
FDA sends Aeglea BioTherapeutics a refusal-to-file letter for its BLA for pegzilarginase, indicated for treating arginase 1 defici...[ Price : $8.95]
FDA sets 1/29/23 as the PDUFA action date for a Pfizer/Myovant sNDA to update the labeling of Myfembree.[ Price : $8.95]
Atrium Medical recalls its iCast Covered Stent System after receiving increased customer complaints about the balloon or catheter ...[ Price : $8.95]
Three doctors sue FDA over the agencys efforts to prevent the use of ivermectin to treat Covid-19.[ Price : $8.95]
Sens. Hassan and Paul introduce a bill to require FDA to more clearly identify differences between a generic and its reference-lis...